From the Guidelines
Individuals with the MTHFR A1298C homozygous mutation should consider supplementing with methylfolate (400-1000 mcg daily) and vitamin B12 (methylcobalamin form, 500-1000 mcg daily) to support methylation processes, as these supplements have been shown to be beneficial in reducing the risk of stroke and other health conditions associated with this mutation 1. The MTHFR A1298C homozygous mutation reduces the enzyme's activity by about 30-40%, which is less severe than the C677T mutation. This mutation affects methylation processes and may impact neurotransmitter production and detoxification pathways. Some key points to consider:
- Most people with this mutation don't require specific treatment if they're asymptomatic.
- If symptoms are present, supplementing with methylfolate rather than regular folic acid may be beneficial, as this is the active form the body can use directly.
- Adding vitamin B12 (methylcobalamin form) can work synergistically with methylfolate.
- Maintaining adequate B6 intake through diet or supplements is also important for proper methylation.
- These supplements are generally safe, but it's recommended to start with lower doses and increase gradually.
- A balanced diet rich in leafy greens, legumes, and quality proteins supports methylation pathways naturally, as shown in studies such as 2, which highlights the importance of diet and supplementation in managing homocysteine levels. While this mutation has been associated with various health conditions, the clinical significance remains controversial, and many people with this genetic variant live normal, healthy lives without any intervention.
From the Research
MTHFR Gene Mutation Homozygous for the A1298C Variant
- The A1298C mutation in the MTHFR gene has been studied for its potential effects on homocysteine metabolism and folate concentrations 3.
- Research has shown that homozygotes for the A1298C mutation do not have elevated plasma total homocysteine concentrations 3.
- A study found that subjects with the 677CC/1298CC genotype had significantly lower concentrations of plasma total homocysteine than those with a 677CC/1298AA genotype 3.
Relationship with Folate Metabolism
- The A1298C variant did not influence plasma homocysteine, folate, 5-methyltetrahydrofolate, vitamin B12, or RBC folate 4.
- Supplementation with 5-MTHF (5-methyl tetrahydrofolate) instead of synthetic folic acid may be beneficial for individuals with MTHFR mutations, including the A1298C variant 5.
Pregnancy Outcome and MTHFR Mutations
- A study found that supplementation with methylfolate, vitamins B6 and B12 in women with MTHFR mutations, including the A1298C variant, had a beneficial effect on pregnancy outcome 6.
- The study showed that supplementation induced a decrease in homocysteine concentrations and improved pregnancy outcomes in women with recurrent pregnancy loss and MTHFR mutations 6.
Coronary Artery Disease and MTHFR Mutations
- Research has found that the A1298C mutation is not associated with increased total plasma homocysteine, and does not appear to play a major role in homocysteine metabolism 7.
- The study suggested that MTHFR genotypes may interfere with coronary artery disease risk only when an unbalanced nutritional status leads to raised total plasma homocysteine levels 7.